In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UC San Francisco.
Alan P. Venook MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.
UC San Francisco researchers have developed a new method for comparing massive numbers of CAR-T cells, each with slightly different molecular features, to determine which is most effective and long-lasting against cancer.
First Lady Jill Biden, PhD, met with top UC San Francisco cancer leaders during a visit Friday to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot. The visit was timed to mark Breast Cancer Awareness Month in October.
On September 24th, the Prostate Cancer Action Network (PCAN) of the San Francisco Cancer Initiative (SFCAN) hosted a Blue-Ribbon Car Show at the UCSF Mission Bay campus to raise awareness about the risk of prostate cancer in the African American community.
A UC San Francisco-led team of international researchers has outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer.
Dr. Hala Borno, a University of California, San Francisco (UCSF) oncologist and experienced health equity researcher, introduced a new, tech-enabled approach that prioritizes the need for diverse and underrepresented patient groups.
Announcing the Cancer Center See Us Portrait Project, a series of portraits and quotes by Black, Indigenous, People of Color (BIPOC) faculty and staff who are dedicated leaders in diversity, equity, and inclusion, and exhibit UCSF's PRIDE values.
